Aims To evaluate the prognostic value of positron emission tomography (PET) imaging in patients with choroidal melanoma.
Methods We undertook a retrospective review of 40 consecutive patients with choroidal melanoma who underwent pretreatment whole-body PET, received either brachytherapy using ruthenium-106 plaque, enucleation or gamma knife radiotherapy, and had 1 year of follow-up. Metabolic activity of choroidal melanoma measured as standardised uptake value (SUV) by PET imaging was evaluated with respect to the survival of patients.
Results SUV (p=0.003) and the largest basal diameter of the tumour (p=0.003) were significantly correlated with metastatic death (Cox proportional hazards regression). There was an inverse correlation between tumour metabolic activity and time to metastasis (p=0.049; linear regression).
Conclusion Metabolic activity by PET imaging significantly predicted the survival of patients with choroidal melanoma.
- uveal melanoma
Statistics from Altmetric.com
Presented in part at the World Molecular Imaging Conference, 8–11 September 2010, Kyoto, Japan.
Funding This work was supported by a National Research Foundation of Korea Grant funded by the Korean Government (2009-0077504).
Competing interests None declared.
Ethics approval This study was conducted with the approval of the Yonsei University College of Medicine.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.